Breast Flashcards
What are typical presentations of breast disease?
Breast lump.
Abnormal screening mammogram.
Nipple discharge.
What are appropriate investigations for breast disease?
Clinical examination.
Imaging- Sonography, mammography & MRI
Pathology (cytopathology and/or histopathology).
How are pathology investigations conducted?
Cytopathology/biopsy
Lesion aspirated by a 16/18gauge needle
What is cytopathology?
Cells spread across a slide and stained. Good cellular detail & quick to prepare but no architecture.
In breast disease used in the investigation of nipple discharge and palpable lumps.
How are breast lump aspirates coded?
Aspirates of breast lumps are coded C1-5:
C1: Inadequate
C2: Benign
C3: Atypical, probably benign
C4: Suspicious of malignancy
C5: Malignant
What is histopathology?
Intact tissue removed, fixed in formalin, embedded in paraffin wax, thinly sliced, stained with H&E.
Core biopsies, surgical excisions. Takes 24 hours to process.
Architectural & cellular detail.
What is duct ectasia?
Inflammation and dilation of large breast ducts.
Aetiology unclear.
Usually presents with nipple discharge. Sometimes causes breast pain, breast mass and nipple retraction.
Cytology of nipple discharge shows proteinaceous material and inflammatory cells only. Benign condition with no increased risk of malignancy.
What is acute mastitis?
Acute inflammation in the breast. Often seen in lactating women due to cracked skin and stasis of milk. May also complicate duct ectasia.
Staphylococci the usual organism.
Presents with a painful red breast. Drainage & antibiotics usually curative.
What is fat necrosis?
An inflammatory reaction to damaged adipose tissue.
Caused by trauma, surgery, radiotherapy.
Presents with a breast mass.
Benign condition.
What is fibrocystic disease?
A group of alterations in the breast which reflect normal, albeit exaggerated, responses to hormonal influences.
Very common.
Presents with breast lumpiness.
No increased risk for subsequent breast carcinoma
What is a fibroadenoma?
A benign fibroepithelial neoplasm of the breast.
Common.
Presents as a circumscribed mobile breast lump in young women aged 20-30.
Simple “shelling out” curative.
What is a Phyllodes tumour?
A group of potentially aggressive fibroepithelial neoplasms of the breast.
Uncommon tumours.
Present as enlarging masses in women aged over 50. Some may arise within pre-existing fibroadenomas.
Vast majority behave in a benign fashion but a small proportion can behave more aggressively.
What is an intraductal papilloma?
A benign papillary tumour arising within the duct system of the breast.
Arise within small terminal ductules (peripheral papillomas) or larger lactiferous ducts (central papillomas).
Summarise the epidemiology and presentation of an intraductal papilloma.
Common.
Seen mostly in women aged 40-60.
Central papillomas present with nipple discharge. Peripheral papillomas may remain clinically silent if small. Excision of involved duct is curative.
What are radial scars?
A benign sclerosing lesion characterised by a central zone of scarring surrounded by a radiating zone of proliferating glandular tissue.
Range in size from tiny microscopic lesions to large clinically apparent masses.
Lesions >1 cm are sometimes called “complex sclerosing lesions”.
How do radial scars present?
Reasonably common lesions.
Thought to represent an exuberant reparative phenomenon in response to areas of tissue damage in the breast.
Usually present as stellate masses on screening mammograms which may closely a carcinoma.
Excision is curative.
What are proliferative breast diseases?
A diverse group of intraductal proliferative lesions of the breast associated with an increased risk, of greatly different magnitudes, for subsequent development of invasive breast carcinoma.
Microscopic lesions which usually produce no symptoms.
Diagnosed in breast tissue removed for other reasons or on screening mammograms if they calcify.
What is usual epithelial hyperplasia?
Not considered a direct precursor lesion to invasive breast carcinoma but is a marker for a slightly increased risk (relative risk of 1.5-2.0) for subsequent invasive carcinoma.
What is flat epithelial atypia/atypical ductal carcinoma?
Emerging genetic data suggests FEA may represent the earliest morphological precursor to low grade ductal carcinoma in situ.
4 times relative risk of developing cancer.
What is in situ lobular neoplasia?
Current evidence suggests that in situ lobular neoplasia is a risk factor for subsequent invasive breast carcinoma in either breast in a minority of women.
The relative risk is quoted as between 7-12 times that expected in women without lobular neoplasia.
What is ductal cell carcinoma in situ (DCIS)?
A neoplastic intraductal epithelial proliferation in the breast with an inherent, but not inevitable, risk of progression to invasive breast carcinoma.
Common.
Incidence has markedly increased since the introduction of breast screening programmes.
How is DCIS classified?
85% are detected on mammography as areas of microcalcification.
10% produce clinical findings such as a lump, nipple discharge, or eczematous change of the nipple (Paget’s disease of the nipple).
5% are diagnosed incidentally in breast specimens removed for other reasons.
Subclassified histologically into low, intermediate and high grade.
What is the treatment of DCIS?
Treatment is surgical excision.
Complete excision with clear margins is curative.
Recurrence is more likely with extensive disease and high grade DCIS.
What are invasive breast carcinomas?
A group of malignant epithelial tumours which infiltrate within the breast and have the capacity to spread to distant sites.
The most common cancer in women with a lifetime risk of 1 in 8.
Incidence rates rise rapidly with increasing age, such that most cases occur in older women.
What are risk factors for invasive breast carcinomas?
Early menarche, late menopause, increased weight, high alcohol consumption, oral contraceptive use, and a positive family history are all associated with increased risk.
About 5% show clear evidence of inheritance. BRCA mutations cause a lifetime risk of invasive breast carcinoma of up to 85%.
What is the clinical presentation of invasive breast carcinomas?
Most cases present symptomatically with a breast lump.
An increasing proportion of asymptomatic cases are detected on screening mammography.